Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Does adrenal DHEA-S decline with age and supply the precursor for peripheral androgen and estrogen synthesis in postmenopausal women?

Adrenal DHEA-S production declines with age yet DHEA remains the key precursor for peripheral synthesis of androgens and estrogens after menopause.

SupportedJune 19, 202615 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

In postmenopausal women, adrenal production of DHEA-S declines with age and DHEA is a precursor for peripheral androgen and estrogen synthesis.

laying out figure…
All 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that a gradual age-related fall in adrenal DHEA-S (adrenopause driven by zona reticularis changes and reduced steroidogenic enzyme activity) occurs but often stabilizes around the menopausal transition. It also states that peripheral tissues convert DHEA/DHEA-S into androgens and estrogens via local enzymes, allowing local intracrine production of sex steroids after ovarian function ceases.

Verified conclusion

In postmenopausal women, the adrenal gland serves as the primary source of hormonal precursors that maintain local steroid concentrations across various tissues. Research into dehydroepiandrosterone (DHEA) and its sulfate form (DHEA-S) confirms their role as critical prohormones during the postmenopausal years.

Age-related decline in adrenal DHEA-S

Adrenal production of DHEA-S undergoes a physiological decline known as adrenopause, which begins between the ages of 30 and 40. This trajectory continues through the postmenopausal years, though the rate of decline varies by stage.

  • Mechanistic drivers: The decline is primarily caused by atrophy of the zona reticularis in the adrenal cortex and a reduction in the activity of the enzyme CYP17A1, which is essential for androgen synthesis.
  • Postmenopausal stability: Longitudinal data, such as from the Study of Women’s Health Across the Nation (SWAN), indicate that while levels decrease over the long term, DHEA-S often stabilizes or plateaus during the immediate transition following the final menstrual period (FMP). Unlike the rapid drop in ovarian estrogens, the adrenal decline is gradual.

Peripheral synthesis of sex steroids

Following the cessation of ovarian function, nearly 100% of sex steroids in postmenopausal women are derived from adrenal DHEA and DHEA-S through a process termed "intracrinology."

  • Androgen synthesis: Peripheral tissues (such as muscle, skin, and bone) convert DHEA into active androgens like testosterone and dihydrotestosterone (DHT) using local enzymes (3β-HSD and 17β-HSD). Tracer studies suggest approximately 2–5% of circulating DHEA is converted directly into testosterone.
  • Estrogen synthesis: DHEA serves as the substrate for estrone (E1) and estradiol (E2) production. It is first converted to androstenedione and then transformed into estrogens via the aromatase enzyme. Tracer data show a conversion efficiency of approximately 0.5–1.5% for estradiol.
  • Local regulation: This peripheral conversion allows specific tissues to regulate their own hormonal environments locally without increasing systemic circulating levels of active estrogens or androgens.

Bottom line

In postmenopausal women, DHEA-S production declines as part of general adrenal aging, though it remains relatively stable during the immediate years after menopause. DHEA is the essential precursor for virtually all peripheral androgen and estrogen synthesis in the postmenopausal state, providing a localized source of sex steroids after ovarian function has ceased.

References

  1. Cellular Senescence in Adrenocortical Biology and Its Disorders — mdpi.com ↗
  2. Adrenopause – does it really exist? — pmc.ncbi.nlm.nih.gov ↗
  3. From adrenarche to aging of adrenal zona reticularis: precocious female adrenopause onset — pmc.ncbi.nlm.nih.gov ↗
  4. The Age-Dependent Changes of the Human Adrenal Cortical Zones Are Not Congruent. — pmc.ncbi.nlm.nih.gov ↗
  5. Intracrinology in action: importance of extragonadal sex steroid biosynthesis and inactivation in peripheral tissues in both women and men. — linkinghub.elsevier.com ↗
  6. All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause. — linkinghub.elsevier.com ↗
  7. Steroid sulfatase and sulfotransferases in the estrogen and androgen action of gynecological cancers: current status and perspectives — portlandpress.com ↗
  8. Science of intracrinology in postmenopausal women — journals.lww.com ↗
  9. Androgen production and conversion to estrogens in normal postmenopausal women and in selected breast cancer patients. — academic.oup.com ↗
  10. Source of Estrogen Production in Postmenopausal Women — academic.oup.com ↗
  11. Androgen-estrogen production rates in postmenopausal women with breast cancer. — semanticscholar.org ↗
  12. Cellular Senescence in Adrenocortical Biology and Its Disorders — mdpi.com ↗
  13. Changes in androstenedione, dehydroepiandrosterone, testosterone, estradiol, and estrone over the menopausal transition — pmc.ncbi.nlm.nih.gov ↗
  14. Circulating dehydroepiandrosterone sulfate concentrations during the menopausal transition. — pmc.ncbi.nlm.nih.gov ↗
  15. Menopausal transition stage–specific changes in circulating adrenal androgens — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→